Unum Therapeutics unumrx.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Unum Therapeutics is a clinical stage biopharmaceutical company developing cellular immunotherapies for the treatment of many different cancers. Unum develops combination cancer therapies using recent advances in T-cell engineering and antibody therapeutics. Its proprietary Antibody-Coupled T-Cell Receptor (ACTR) may be used in combination with a variety of cancer-specific antibodies to treat different cancer types.

Unum Therapeutics is a clinical stage biopharmaceutical company developing cellular immunotherapies for the treatment of many different cancers. Unum develops combination cancer therapies using recent advances in T-cell engineering and antibody thera...Show all

Company (IPO / Went public)

Phone: 617-945-5576

Fax:

200 Cambridge Park Drive
Suite 3100
Cambridge, 02140
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Unum Therapeutics $161.2M Mar 29, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Unum Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 14 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Chimeric receptors and uses thereof in immune therapy Sep 09, 2015 Application